Brussels, Belgium

Gezim Bala



 

Average Co-Inventor Count = 9.0

ph-index = 1


Company Filing History:


Years Active: 2017

Loading Chart...
Loading Chart...
Loading Chart...
1 patent (USPTO):Explore Patents

Title: Gezim Bala - Innovator in Cardiovascular Imaging

Introduction

Gezim Bala is a notable inventor based in Brussels, Belgium. He has made significant contributions to the field of cardiovascular diseases through his innovative research and patents. His work focuses on the development of immunoglobulin single variable domains that can aid in the diagnosis and treatment of cardiovascular conditions.

Latest Patents

Gezim Bala holds a patent titled "Method of imaging a cardiovascular disease with an anti-macrophage mannose receptor immunoglobulin single variable domain." This patent relates to the field of cardiovascular diseases, specifically targeting macrophage mannose receptors (MMR). The immunoglobulin single variable domains developed by Bala can be utilized for diagnosing, prognosing, and monitoring cardiovascular diseases. They are particularly effective in the in vivo targeting and imaging of vulnerable atherosclerotic plaques, which are critical in managing post-infarction cardiovascular events.

Career Highlights

Throughout his career, Gezim Bala has worked with various organizations, including Vib Vzw and Vrije Universiteit Brussel. His experience in these institutions has allowed him to collaborate with leading experts in the field and contribute to groundbreaking research in cardiovascular health.

Collaborations

Some of his notable coworkers include Patrick De Baetselier and Geert Raes. Their collaborative efforts have further advanced the understanding and treatment of cardiovascular diseases.

Conclusion

Gezim Bala's innovative work in cardiovascular imaging and his patent contributions highlight his role as a key figure in medical research. His advancements in immunoglobulin technology are paving the way for improved diagnostic and therapeutic strategies in cardiovascular health.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…